Yatharth Hospitals Q4 Profit Up 1% on ₹232 Cr Revenue, Expands Capacity with New Hospitals
Team Finance Saathi
26/May/2025

What's covered under the Article:
-
Yatharth Hospitals’ Q4 net profit rose 1% YoY to ₹39 crore on a 30.6% increase in revenue to ₹232 crore, driven by higher ARPOB and occupancy.
-
EBITDA grew 22.7% to ₹57.2 crore despite narrowing margin, supported by strong cash flows and a robust ₹5,032 crore net cash position.
-
The company expanded capacity by acquiring two new hospitals in Delhi and Faridabad, expected to start operations in Q1 FY26, enhancing its growth outlook.
Yatharth Hospitals, a prominent healthcare provider in India, announced its financial results for the fourth quarter (Q4) of FY25, reporting steady growth in key metrics that underline the company’s strong operational and financial health. Despite challenging market conditions, the hospital chain demonstrated resilience with a 1% year-on-year (YoY) increase in net profit to ₹39 crore, compared to ₹38.3 crore in the same quarter last year.
Revenue and Profit Growth
The company’s revenue from operations surged 30.6% YoY to ₹232 crore, significantly higher than ₹177.7 crore in Q4 FY24. This strong top-line growth was primarily driven by higher Average Revenue Per Occupied Bed (ARPOB) and improved bed occupancy rates. ARPOB rose 7% YoY in Q4 to ₹31,441, with notable contributions from strategic locations like Noida Extension and Greater Noida, where ARPOB increased by 12% and 20%, respectively. The company’s focus on super-specialty services in these regions helped drive these gains.
EBITDA and Margins
Yatharth Hospitals also reported a robust 22.7% increase in EBITDA, which rose to ₹57.2 crore from ₹46.6 crore a year earlier. However, EBITDA margin experienced a slight decline to 24.66% from 26.22% in the previous year’s quarter, reflecting ongoing investments in expanding services and capacity. Despite this margin contraction, the company’s EBITDA growth highlights effective cost management and operational leverage.
Operational Efficiency and Cash Flow
A critical highlight for Yatharth is its strong cash position and cash flow generation. The company ended FY25 with a net cash balance of ₹5,032 crore and operating cash flows of ₹1,496 crore for the year, achieving an impressive 68% cash conversion ratio. This cash strength not only supports ongoing operations but also enables the company to pursue expansion and innovation without heavy reliance on external financing.
Capacity Expansion and Future Growth
Yatharth Hospitals has been aggressively expanding its infrastructure to meet rising healthcare demand. Recently, the company took possession of two new hospital facilities – a 300+ bed hospital in Delhi and a 400-bed hospital in Faridabad. Both are expected to commence operations in Q1 FY26, significantly increasing the company’s bed capacity and strengthening its presence in key urban areas.
Strategic Location and Accreditation
Established in 2008, Yatharth Hospitals operates multiple multi-specialty hospitals across Delhi NCR and Madhya Pradesh, with a combined capacity exceeding 2,300 beds. The Greater Noida West facility stands out as the first and only Joint Commission International (JCI) accredited hospital in Uttar Pradesh, underscoring the company’s commitment to high-quality healthcare standards.
Stock Performance and Market Position
Yatharth Hospitals went public with an IPO in August 2023, raising ₹686.55 crore with overwhelming demand (36 times subscription). Its shares are actively traded on the National Stock Exchange (NSE), recently valued at ₹520.05, with a 52-week trading range from ₹345.60 to ₹693.00. The current market capitalization is approximately ₹5,231.71 crore, reflecting investor confidence in the company’s growth potential.
Outlook
With the addition of new hospitals and continued focus on high-margin specialty services, Yatharth Hospitals is well-positioned for sustained growth in FY26 and beyond. The company’s strategy to enhance ARPOB, improve bed occupancy, and maintain strong cash flows will likely drive profitability while supporting expansion into new markets.
Summary
Yatharth Hospitals’ Q4 FY25 financials indicate solid growth driven by higher revenues, operational efficiency, and strategic capacity expansion. The company’s strong cash position and new hospital facilities position it well to capitalize on growing healthcare demand in India, making it a key player to watch in the healthcare sector.
The Upcoming IPOs in this week and coming weeks are 3B Films, N R Vandana Tex Industries, Scoda Tubes,Neptune Petrochemicals, Astonea Labs, Nikita Papers, Prostarm Info Systems, Victory Electric Vehicles International, Blue Water Logistics, Wagons Learning.
The Current active IPO are Aegis Vopak Terminals, Schloss Bangalore, Unified Data - Tech Solutions.
Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.
Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.
Related News
Disclaimer
The information provided on this website is for educational and informational purposes only and should not be considered as financial advice, investment advice, or trading recommendations.
Trading in stocks, forex, commodities, cryptocurrencies, or any other financial instruments involves high risk and may not be suitable for all investors. Prices can fluctuate rapidly, and there is a possibility of losing part or all of your invested capital.
We do not guarantee any profits, returns, or outcomes from the use of our website, services, or tools. Past performance is not indicative of future results.You are solely responsible for your investment and trading decisions. Before making any financial commitment, it is strongly recommended to consult with a qualified financial advisor or do your own research.
By accessing or using this website, you acknowledge that you have read, understood, and agree to this disclaimer. The website owners, partners, or affiliates shall not be held liable for any direct or indirect loss or damage arising from the use of information, tools, or services provided here.